The 10th U.S. Circuit Court of Appeals reinstated some claims on Friday brought on behalf of a former professor in a dispute with Brigham Young University about how to split part of BYU's 2012 $450 million settlement with Pfizer over its blockbuster arthritis drug Celebrex.